INTRODUCTION
Salmonella enterica serovar Typhimurium is a leading cause of foodborne gastroenteritis in humans (Liljebjelke et al., 2005; CDC, 2006) and is commonly associated with gastroenteritis caused by the consumption of Salmonella-contaminated broiler chicken meat (Rabsch et al., 2001; Ferris et al., 2002; Zhang et al., 2003; CDC, 2006) . Intestinal infection by Salmonella is known to systemically infect chicks less than 3 d old but cause subclinical infection in older birds (Barrow et al., 1987b (Barrow et al., , 2003 Humphrey, 1999) . Although older birds do not express clinical disease, colonization often leads to fecal shedding that promotes horizontal transmission within the flock, and subsequent cross-contamination of carcass or harvested meat during slaughter and processing (Barrow et al., 1987a; Humphrey, 1999; Salyers, 2002) . As a result, there have been ongoing efforts to reduce Salmonella colonization in the intestines and ceca of broilers.
In poultry, intestinal pathogen colonization is typically controlled through prophylactic administration of broad-spectrum antibiotics in feed. In recent years, increasing numbers of antibiotic-resistant isolates of Salmonella have been found (Low et al., 1997; kiessling et al., 2002; CDC, 2006) . In addition, there is increasing consumer and governmental pressures to reduce or remove drugs from feed manufactured for food animals (Young and Craig, 2001 ). These factors have promoted the exploration of a variety of nonantibiotic antimicrobial feed additives, which includes the administration of immunonutrients. Immunonutrients such as glutamine are nutrients that are capable of enhancing (upregulating) or downregulating immune responses to a pathogen or disease condition (koretz, 2003) and may therefore reduce pathogen levels.
Glutamine is an important constituent of proteins and is a precursor for the synthesis of amino acids, nucleotides, nucleic acids, amino sugars, and several other biologically important molecules (Souba, 1993; Roth, 2008) . Furthermore, glutamine is the main energy substrate for rapidly proliferating cells such as enterocytes and activated lymphocytes in the intestinal epithelium (Calder and Yaqoob, 1999) . As an immunonutrient, glutamine is important for promoting the integrity and maturation of intestinal microflora associated with the immune system, for enhancing mucin synthesis to maintain intestinal mucosa structure, and for reinforcing the epithelial barrier against bacterial attacks (khan et al., 1999; Yi et al., 2005 ). An important study that demonstrates the immunomodulatory potential of glutamine was reported by Domeneghini et al. (2004) . They studied the effect of dietary l-glutamine and nucleotide supplementation on ileal mucosa in female weaning piglets randomly allocated to 4 treatments. Results obtained showed that glutamine or nucleotide supplementation, or both, increased (P < 0.01) the number of mucosal macrophages and intraepithelial lymphocytes in the ileum of the piglets.
It has been suggested that glutamine is a conditionally essential amino acid during inflammatory conditions such as infection and injury (Newsholme, 2001) . Although conflicting results exist on the efficacy of glutamine in alleviating disease conditions, most studies have reported that glutamine supplementation is beneficial in disease conditions. For instance, results from 2 placebo-controlled trials examining the effect of glutamine supplementation (2.5 g/5 mL of Saforis solution/d) on oral mucositis in humans showed that glutamine reduced the incidence (P = 0.026) and severity (P = 0.005) of oral mucositis during anthracyclinebased chemotherapy (Peterson et al., 2007) . In another trial, Li et al. (2006) found no beneficial effect on stomatitis and diarrhea when they gave humans some glutamine (30 g in water/d) during neoadjuvant chemotherapy. Souba (1997) also reported that glutamine reduced bacterial translocation in animals. More recently, Margaritis et al. (2005) found that glutamine supplementation alleviated the bacterial translocation and endotoxemia associated with obstructive jaundice when they orally administered glutamine (4.5 g/kg per d in drinking water) to male Wistar rats that are experimental models of obstructive jaundice in humans. Variability in the efficacy of glutamine in disease conditions may be due to differences in the dose and disease being investigated.
Although it has been well established that supplementation of glutamine at 1% level of the diet improves growth performance and stimulates intestinal development (Yi et al., 2005; Bartell and Batal, 2007; Murakami et al., 2007) , only the study by Yi et al. (2005) evaluated the efficacy of glutamine in alleviating an enteric disease condition. In this study, broiler chicks were either starved, given feed, or given Oasis (a hydrated nutritional supplement for newly hatched poultry; Novus International Inc., St. Louis, MO) with or without 1% glutamine supplementation for 48 h posthatch. Afterward, chicks were given a common starter feed and subsequently challenged at 22 d of age with 4 × 10 4 viable sporulated oocysts of Eimeria maxima/bird. Results indicated that supplementing Oasis with 1% glutamine reduced the incidence of E. maxima-induced lesions in the intestines of broiler chicks.
The goal of this study is to evaluate the effect of dietary glutamine supplementation at 1% level of the diet on intestinal colonization by Salmonella Typhimurium.
MATERIALS AND METHODS
Two experiments were conducted. All of the procedures used in this study were approved by the Auburn University Institutional Animal Care and Use Committee.
Preparation of Bacteria Inoculum
Salmonella Typhimurium obtained from poultry was spontaneously mutated to become resistant to 35 μg of nalidixic acid/mL (Haroldo Toro, Department of Pathobiology, Auburn University) and used to challenge chicks in this study. The Salmonella Typhimurium inoculum used for chick challenge was prepared as described previously by Fasina et al. (2008) .
Experimental Birds and Treatments
In experiment 1, straight-run broiler chicks (146; Ross × Ross 708) were obtained from a commercial hatchery and transported to the Auburn University Poultry Research Farm for experimentation. To confirm that chicks were free of Salmonella Typhimurium upon arrival at the farm, 20 chicks were randomly taken, killed by CO 2 asphyxiation, and aseptically necropsied for the removal of ceca. Cecal contents were then inoculated into sterile tetrathionate and Rappaport-Vassiliadis broths (Acumedia Manufacturers Inc., Baltimore, MD) that were incubated at 42°C (Precision 30M High Capacity Incubator, Precision Scientific, Winchester, VA) for 24 h. Resulting tetrathionate and Rappaport-Vassiliadis cultures were streaked onto xylose lysine tergitol 4 (XLT4) agar plates. After 48 h at 37°C, presumptive Salmonella Typhimurium colonies were isolated and confirmed by transference into triple sugar iron and lysine iron agar (Acumedia Manufacturers Inc.) as described by the USDA Laboratory Guide (USDA, 2004) . The remaining 126 chicks were randomly divided into 3 treatments as follows: i) treatment 1 (control, CN) consisted of chicks given an unmedicated corn-soybean meal (SBM)-based starter diet without glutamine supplementation or Salmonella Typhimurium challenge; ii) treatment 2 (CST) consisted of chicks given an unmedicated corn-SBM starter diet without glutamine supplementation but challenged with 3.6 × 10 6 cfu Salmonella Typhimurium/mL of buffered peptone water (BPW) at 3 d of age; iii) treatment 3 (GST) consisted of chicks given an unmedicated corn-SBM starter diet supplemented with glutamine at 1% level and challenged with 3.6 × 10 6 cfu Salmonella Typhimurium/ mL of BPW at 3 d of age. Chicks in the CN treatment were mock-challenged with 1 mL of sterile BPW. Each experimental treatment consisted of 3 replicate pens with 14 chicks per pen. All pens were in Petersimeraised wire batteries (Petersime Incubator Co., Gettysburg, OH) maintained at 30 ± 2°C during the first week, after which temperature was gradually reduced weekly by 2°C. Continuous lighting and access to feed and water was provided throughout the experiment. Experimental diets (Table 1) were formulated to meet the recommendations of the NRC (1994). Duration of experiment was 2 wk.
In experiment 2, straight-run broiler chicks (276; Ross × Ross 708) were obtained from a commercial hatchery and transported to Auburn University Poultry Research Farm. Upon arrival at the farm, 20 chicks were randomly taken and confirmed free of Salmonella Typhimurium as described previously for experiment 1. The remaining 256 chicks were randomly divided into 4 experimental treatments as follows: i) treatment 1 was similar to the CN treatment in experiment 1; ii) treatment 2 was similar to the CST treatment in experiment 1 except that the dose of Salmonella Typhimurium used for challenge at 3 d of age was 7.4 × 10 7 cfu Salmonella Typhimurium/mL of BPW; iii) treatment 3 (GST) consisted of chicks given an unmedicated corn-SBM starter diet supplemented with glutamine at 1% level and challenged with 7.4 × 10 7 cfu Salmonella Typhimurium/ mL of BPW at 3 d of age; and iv) treatment 4 (GL) consisted of chicks given a diet similar to that of GST, but the chicks were not challenged with Salmonella Typhimurium. Chicks in the CN and GL treatments were mock-challenged with 1 mL of sterile BPW. Each treatment consisted of 4 replicate pens with 16 chicks per pen. Chicks were raised under similar environmental conditions as described for experiment 1 and the composition of corn-SBM starter diet was similar. Duration of experiment was 2 wk.
Monitoring Chick Growth Performance
On a weekly basis, BW, BW gain, and feed conversion (FC) efficiency were calculated. Mortality was also recorded on a daily basis.
Recovery of Viable Salmonella Typhimurium from Ceca of Challenged Chicks
To confirm the presence of infection, Salmonella Typhimurium was enumerated in the ceca of chicks as follows. In experiment 1, four chicks were randomly taken from each pen on d 4 and 10 postchallenge (PC). In experiment 2, four chicks were randomly taken from each pen on d 4 and 11 PC. In each experiment, the chicks taken were killed by CO 2 asphyxiation and aseptically necropsied for the removal of the ceca. The pair of ceca removed from each chick was placed in separate WhirlPak filter bags (Nasco, Fort Atkinson, WI) containing 25 mL of sterile BPW, and contents were homogenized at 230 rpm for 60 s (Stomacher 400 Circulator, Seward Limited, London, Uk) before serial dilution (serial 10-fold dilutions up to 10 5 ). From each dilution, 1 mL was taken and plated on XLT4 agar supplemented with nalidixic acid (35 μg/mL). The XLT4 plates were incubated for 48 h at 37°C and then black presumptive Salmonella Typhimurium colonies were counted. Total concentration of Salmonella Typhimurium in the pair of ceca from each chick was expressed as log 10 colonyforming units per milliliter.
Statistical Analysis
The experimental unit for all data was pen average. Growth performance data (BW, BW gain, and FC) and ceca Salmonella Typhimurium counts were subjected to 1-way ANOVA using the GLM procedure of SAS (SAS Institute, 2004) . Mortality data were subjected to arcsine square root transformation and subsequently analyzed by ANOVA (SAS Institute, 2004 ). Significant differences among means were determined by using the Duncan option of the GLM procedure as a post hoc test (Waller and Duncan, 1969 ; SAS Institute, 2004). 1 CN = control chicks fed corn-soybean meal (SBM) basal diet with no glutamine supplementation, and not challenged with Salmonella Typhimurium; CST = chicks fed corn-SBM basal diet with no glutamine supplementation, and challenged with 3.6 × 10 6 cfu Salmonella Typhimurium/chick at 3 d of age; GST = chicks fed corn-SBM basal diet containing 1% glutamine supplementation, and challenged with 3.6 × 10 6 cfu Salmonella Typhimurium/ chick at 3 d of age.
2 Values are based only on weight of live birds. 3 Feed conversion (FC) was calculated as feed:gain ratio and was adjusted for mortality by using the gains of the dead birds in the calculations. 1 CN = control chicks fed corn-soybean meal (SBM) basal diet with no glutamine supplementation, and not challenged with Salmonella Typhimurium; CST = chicks fed corn-SBM basal diet with no glutamine supplementation, and challenged with 7.4 × 10 7 cfu Salmonella Typhimurium/chick at 3 d of age; GL = chicks fed corn-SBM basal diet supplemented with 1% glutamine, but no Salmonella Typhimurium challenge; GST = chicks fed corn-SBM basal diet supplemented with 1% glutamine, and challenged with 7.4 × 10 7 cfu Salmonella Typhimurium/chick at 3 d of age.
2 Values are based only on weight of live birds. 3 Feed conversion (FC) was calculated as feed:gain ratio and was adjusted for mortality by using the gains of the dead birds in the calculations.
Data are presented as means ± SEM. Statements of statistical significance were based upon P < 0.05.
RESULTS AND DISCUSSION
Growth performance data for chicks in all treatments are presented in Tables 2 and 3 for experiments 1 and 2, respectively. Throughout experiment 1, there were no differences in the BW, BW gain, and FC of chicks in all treatments (CN, CST, and GST; Table 2 ). Similarly, in experiment 2, there were no differences in BW, BW gain, and FC of chicks among CN, CST, and GST treatments (P > 0.05; Table 3 ). However, the GL treatment added in experiment 2 gave higher BW and BW gain compared with the other treatments (P < 0.05). The BW gain values obtained in this study for the GL treatment (113 g/chick on d 7; 352 g/chick on d 14) were similar to those obtained by Bartell and Batal (2007;  110 g/chick on d 7; 371 g/chick on d 14) when they gave broiler chicks a similar corn-SBM diet supplemented with 1% glutamine. It is also possible that the higher lysine content in the diet containing 1% glutamine (1.27%; Table 1 ) compared with the level in glutamine-free diet (1.24%) contributed to the higher BW and BW gain observed for the GL treatment. Total mortality was 1 and 4% for experiments 1 and 2, respectively. There were no differences in mortality among treatments in either experiment (P = 0.7407 in experiment 1; P = 0.0757 in experiment 2).
Level of Salmonella Typhimurium recovered from the ceca of challenged chicks (CST and GST treatments) ranged from 2.37 to 5.12 log 10 cfu/mL at 4 d PC and from 1.64 to 2.94 log 10 cfu/mL at about 11 d PC in both experiments 1 and 2, as opposed to nil values for controls (CN and GL treatments; Table 4 ). This indicates that Salmonella Typhimurium infection was successfully established in CST and GST chicks. However, the lack of a difference (P > 0.05) in cecal Salmonella Typhimurium levels between the Salmonella Typhimurium-challenged treatments (CST and GST) on d 4, 10, and 11 PC (Table 4) implies that the glutaminesupplemented diet did not reduce cecal Salmonella Typhimurium levels as proposed.
The ineffectiveness of glutamine in reducing cecal Salmonella Typhimurium levels in GST chicks may be due to imbalance between the magnitude of intestinal inflammatory immune response to Salmonella Typhimurium and the rate of Salmonella Typhimurium proliferation. It has been well established that intestinal Salmonella Typhimurium infection triggers inflammatory immune response in young broiler chicks (Withanage et al., 2004; Fasina et al., 2008) . Inflammatory immune responses are typified by signaling events that culminate in cellular responses such as increased mucin production, recruitment of phagocytes (heterophils and macrophages) to infection site, activation of microbial-killing mechanisms, production of cytokines and chemokines, maturation of antigen-presenting cells, and recruitment of the adaptive immune response to eradicate infection (Deplancke and Gaskins, 2001; kogut et al., 2005; Akira et al., 2006; Delcenserie et al., 2008) . For instance, in an experiment with postweaning piglets, glutamine supplementation at a 0.5% level of the diet increased the numbers of mucosal macrophages and intraepithelial lymphocytes (Domeneghini et al., 2004 (Domeneghini et al., , 2006 . However, in this study, immunoprotective potential of glutamine against Salmonella Typhimurium infection was not apparent. Ineffectiveness of glutamine to reduce Salmonella Typhimurium levels in the ceca of broiler chicks is probably due to mucin-enhanced proliferation of the Salmonella at a rate that overpowers any ongoing inflammatory antibacterial processes.
Secreted mucins may serve as binding sites for mucolytic enteric pathogens. For instance, it has been established that Salmonella Typhimurium specifically binds to a 250-kDa neutral mucin in the intestinal tract of rats (Vimal et al., 2000) . In this study, perhaps there were enough binding sites in intestinal mucins of chicks in GST treatment to support a higher rate of Salmonella Typhimurium proliferation that surpasses any immunoenhancing effect of glutamine. In addition, dietary glutamine itself along with debris released from 3 Salmonella Typhimurium concentrations in this column represent values obtained on d 10 PC in experiment 1 and d 11 PC in experiment 2.
4 CN = control chicks fed corn-soybean meal (SBM) basal diet with no glutamine supplementation, and not challenged with Salmonella Typhimurium; CST = chicks fed corn-SBM basal diet with no glutamine supplementation, and challenged with 3.6 × 10 6 cfu Salmonella Typhimurium/chick at 3 d of age; GST = chicks fed corn-SBM basal diet containing 1% glutamine supplementation, and challenged with 3.6 × 10 6 cfu Salmonella Typhimurium/chick at 3 d of age.
5 CN = control chicks fed corn-SBM basal diet with no glutamine supplementation, and not challenged with Salmonella Typhimurium; CST = chicks fed corn-SBM basal diet with no glutamine supplementation, and challenged with 7.4 × 10 7 cfu Salmonella Typhimurium/chick at 3 d of age; GL = chicks fed corn-SBM basal diet supplemented with 1% glutamine, but no Salmonella Typhimurium challenge; GST = chicks fed corn-SBM basal diet supplemented with 1% glutamine, and challenged with 7.4 × 10 7 cfu Salmonella Typhimurium/chick at 3 d of age.
transmigrating heterophils and macrophages during the inflammatory process can serve as nutrients for bacteria (Forchhammer, 2007; Stecher et al., 2008) and thus may promote Salmonella Typhimurium proliferation in the ceca of GST chicks.
In summary, for the first time in literature, we have attempted to determine if glutamine supplementation in the diet as an immunomodulatory nutrient can be effective in reducing cecal Salmonella levels in young broiler chicks. Results from this study showed that although supplementing glutamine at 1% level of the diet enhanced growth performance, it did not reduce cecal Salmonella Typhimurium levels. Perhaps the 1% supplemental glutamine level used in this study was not optimal to achieve a reduction in cecal Salmonella Typhimurium. It is increasingly becoming important to base the selection of optimal dietary inclusion levels of bioactive nutrients on the requirements of the immune system, in addition to requirements for bird growth (klasing, 2006) . Further investigation is necessary to determine whether there is an optimum level of supplemental glutamine that will enhance intestinal immunity to Salmonella and reduce the level of this bacteria in the gastrointestinal tract of broiler chickens.
